tirzepatide 10mg ml (weight loss) 10 mg/0.5 subcutaneous solution Zepbound 10 mg/0.5 mL injection
Description
Aging is a disease state
In parallel, the reduction in glycemic burden induced by GLP-1 activity creates a metabolic milieu that may restore GIPR sensitivity and functionality
Although it shares the active ingredient with some weight loss drugs, Ozempic is specifically intended for diabetes control and is not approved for weight loss
Semaglutide is available by prescription only, if deemed clinically appropriate
